These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23657987)

  • 1. siRNA associated with immunonanoparticles directed against cd99 antigen improves gene expression inhibition in vivo in Ewing's sarcoma.
    Ramon AL; Bertrand JR; de Martimprey H; Bernard G; Ponchel G; Malvy C; Vauthier C
    J Mol Recognit; 2013 Jul; 26(7):318-29. PubMed ID: 23657987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
    Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
    Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
    Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
    Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapies in Ewing's sarcoma.
    Scotlandi K
    Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine model for skeletal metastases of Ewing's sarcoma.
    Scotlandi K; Benini S; Manara MC; Serra M; Nanni P; Lollini PL; Nicoletti G; Landuzzi L; Chano T; Picci P; Baldini N
    J Orthop Res; 2000 Nov; 18(6):959-66. PubMed ID: 11192257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
    Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
    Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraskeletal Ewing's sarcoma of the hard palate.
    Kang MS; Yoon HK; Choi JB; Eum JW
    J Korean Med Sci; 2005 Aug; 20(4):687-90. PubMed ID: 16100468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
    Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
    Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
    Guerzoni C; Fiori V; Terracciano M; Manara MC; Moricoli D; Pasello M; Sciandra M; Nicoletti G; Gellini M; Dominici S; Chiodoni C; Fornasari PM; Lollini PL; Colombo MP; Picci P; Cianfriglia M; Magnani M; Scotlandi K
    Clin Cancer Res; 2015 Jan; 21(1):146-56. PubMed ID: 25501132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma.
    Scotlandi K; Perdichizzi S; Bernard G; Nicoletti G; Nanni P; Lollini PL; Curti A; Manara MC; Benini S; Bernard A; Picci P
    Eur J Cancer; 2006 Jan; 42(1):91-6. PubMed ID: 16326096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
    Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
    J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIC2 detection in tumors of bone and adjacent soft tissues.
    Devaney K; Abbondanzo SL; Shekitka KM; Wolov RB; Sweet DE
    Clin Orthop Relat Res; 1995 Jan; (310):176-87. PubMed ID: 7641436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
    Peng W; Huang X; Yang D
    Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2.
    Fellinger EJ; Garin-Chesa P; Triche TJ; Huvos AG; Rettig WJ
    Am J Pathol; 1991 Aug; 139(2):317-25. PubMed ID: 1867320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
    Hu-Lieskovan S; Heidel JD; Bartlett DW; Davis ME; Triche TJ
    Cancer Res; 2005 Oct; 65(19):8984-92. PubMed ID: 16204072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal rearrangement t(11;22) in extraskeletal Ewing's sarcoma and primitive neuroectodermal tumour analysed by fluorescence in situ hybridization using paraffin-embedded tissue.
    Nagao K; Ito H; Yoshida H; Minamizaki T; Furuse K; Yoshikawa T; Ushigome S
    J Pathol; 1997 Jan; 181(1):62-6. PubMed ID: 9072004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
    Kinsey M; Smith R; Lessnick SL
    Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.